Neurosurgery 97:1215–1218, 2025
This report presents two cases of symptomatic intracranial hemorrhage occurring during MR-guided focused ultrasound (MRgFUS) ablation for movement disorders, associated with persistent cavitation activity despite power reductions. Both patients developed contralateral motor deficits after sonications; one recovered substantially, the other remained significantly disabled, and imaging confirmed hematomas at the targeted sites.
The authors review procedural variables, cavitation mechanisms, mitigation strategies, and institutional experience (~500 cases, 0.4% incidence), recommending a conservative approach—including treatment termination—when uncontrollable cavitation arises, and urging further study of patient- and system-related risk factors to minimize bleeding risk.
• MRgFUS Complication: Symptomatic brain bleeding can occur during magnetic resonance–guided focused ultrasound (MRgFUS) ablation for movement disorders, although it is a rare complication (approximately 0.4% incidence in a center with over 500 cases).
• Cavitation Risk: Persistent cavitation—microbubble formation and collapse during sonication—is strongly associated with the occurrence of brain hemorrhage in MRgFUS procedures, even when standard mitigation steps (such as lowering power) are taken.
• Case Outcomes: In two reported cases, both patients developed contralateral motor weakness and brain hematoma following persistent cavitation during MRgFUS; one patient recovered functional independence, while the other remained severely disabled.
• Technical Mitigation: When cavitation is detected, the recommended strategy is to reduce sonication power and, if needed, increase duration to maintain energy delivery; however, if uncontrollable cavitation persists, treatment termination should be considered.
• Patient Factors: Bleeding can occur even in patients without traditional vascular risk factors, suggesting procedural factors like cavitation may be more critical than patient comorbidities in these cases.
• Incidence and Reporting: Over 20,000 MRgFUS procedures have been performed globally with very few reports of symptomatic brain bleeding, highlighting the importance of continued reporting to refine safety practices.
• Clinical Implication: MRgFUS is an effective and generally safe treatment for movement disorders, but it is not without risk; both clinicians and patients should be aware that severe complications, though rare, are possible.
• Best Practice: A conservative approach is advised if cavitation cannot be controlled during MRgFUS, and further study into both technical and patient-related risk factors for hemorrhage is warranted.






You must be logged in to post a comment.